Gene · 6716
Papers1,787
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,787
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Isolated Hypospadias Identified on Fetal Ultrasound: Genetic Investigation Results at a Single Referral Center. | Fetal Diagn Ther | 2026 | 41045475 | PubTator, text mining | PubMed |
| Genetic Etiology of 46, XY Disorders of Sex Development in Chinese Patients: Insights From Whole-Exome Sequencing. | Clin Genet | 2026 | 40976963 | PubTator, text mining | PubMed |
| A Novel SRD5A2 Loss-of-Function Variant in a Chinese Child with 5α-reductase Type 2 Deficiency | J Clin Res Pediatr Endocrinol | 2026 | 40045579 | PubTator, text mining | PubMed |
| Sex testing in women's sport: historical harms, contemporary risks, and World Athletics' 2025 policy shift. | Front Sports Act Living | 2025 | 41743893 | PubTator, text mining | PubMed |
| [Clinical, hormonal and molecular genetic characteristics of 18 cases of disorders of sex development (DSD) 46,XY associated with variants in the SRD5A2 gene]. | Probl Endokrinol (Mosk) | 2025 | 41640146 | PubTator, text mining | PubMed |
Nobiletin mitigates benign prostatic hyperplasia by suppressing prostate cell proliferation through regulation of cell cycle progression, signaling pathways, transcription factor activity, and the androgen-signaling axis. | Front Pharmacol | 2025 | 41446789 | PubTator, text mining | PubMed |
| Integrative analysis reveals SRD5A2 as a central mediator in PPCPs induced modulation of the prostate cancer immune microenvironment. | Discov Oncol | 2025 | 41269424 | PubTator, text mining | PubMed |
| Prognostic and immune microenvironment of a cancer-associated fibroblast-related genes signature for biochemical recurrence in prostate cancer. | Medicine (Baltimore) | 2025 | 41261613 | PubTator, text mining | PubMed |
| [Clinical characteristics and genetic analysis of patients with 46,XY Disorders of sex development and a female phenotype: A single-center study]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2025 | 41230585 | PubTator, text mining | PubMed |
| Identification of a Rare Variant in the SRD5A2 Gene in Siblings With 46,XY Disorders of Sexual Development. | Case Rep Genet | 2025 | 41210722 | PubTator, text mining | PubMed |
| Toxicological Impacts of Polypropylene Nanoparticles Similar in Size to Nanoplastics in Plastic-Bottle Injections on Human Umbilical Vein Endothelial Cells. | Toxics | 2025 | 41012423 | PubTator, text mining | PubMed |
| A scoping review of the role of heritability and environmental exposures in the development and severity of benign prostatic hyperplasia. | Transl Androl Urol | 2025 | 40949435 | PubTator, text mining | PubMed |
| Stromal Steroid 5 Alpha-Reductase 2 Promotes Prostate Growth through WNT5A-Lymphoid Enhancer-Binding Factor 1-Insulin-Like Growth Factor 1 Signaling in Benign Prostatic Hyperplasia. | Am J Pathol | 2025 | 40946793 | PubTator, text mining | PubMed |
| Two Cases of 46,XY Differences of Sex Development Due to Gonadal Dysgenesis Associated With Novel NR5A1 Variants. | JCEM Case Rep | 2025 | 40860577 | PubTator, text mining | PubMed |
| "In silico analysis of human TLR3 missense single nucleotide polymorphisms and their potential association with cancer". | Sci Rep | 2025 | 40847033 | PubTator, text mining | PubMed |
| Molecular Characterization of Steroid 5 Alpha-Reductase 2 (SRD5A2) Gene Variant in Indian Patients with Disorder of Sexual Development. | Arch Sex Behav | 2025 | 40839185 | PubTator, text mining | PubMed |
| Mitochondrial fission genes MTFP1/MTFP2 as predictive biomarkers in prostate cancer: a mendelian randomization study. | Discov Oncol | 2025 | 40824549 | PubTator, text mining | PubMed |
| Diagnostic Accuracy of Serum Steroids and Peptides in the Evaluation of 46, XY Disorders of Sex Development (DSD). | Clin Endocrinol (Oxf) | 2025 | 40799104 | PubTator, text mining | PubMed |
| The diagnostic value of stimulated androgen ratios in 5-alpha reductase type 2 (SRD5A2) deficiency: a case series and review of the literature. | J Pediatr Endocrinol Metab | 2025 | 40768556 | PubTator, text mining | PubMed |
| Scalp acupoint catgut embedding combined with topical 5% minoxidil tincture to improve male androgenetic alopecia: protocol for a randomised controlled trial. | BMJ Open | 2025 | 40754324 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6716/papers?page=3